VIXTICIBART
UNII 3E5N6X8CJF

Substance Identification & Data

This profile provides standardized clinical and technical data for Vixticibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3E5N6X8CJF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2845128-05-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3E5N6X8CJF

CAS Registry Number

2845128-05-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VIXTICIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C207014

National Cancer Institute reference terminology for clinical and research data.

INN ID

12917

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OP-04

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vixticibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

VIXTICIBART

Common Names & Synonyms

H-GAMMA4 HEAVY CHAIN HOMO SAPIENS(1-451) (VH (HOMO SAPIENS IGHV1-2*02 (91.8%) -(IGHD) -IGHJ6*01 (100%), CDR-IMGT (8.8.17) (26-33.51-58.97-113)) (1-124)-HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92, G4V5 H P10 (CH1 (125-222), HINGE 1-12 S10>P (232) (223-234), CH2 L92 (313) (235-344), CH3 (345-449), CHS (450-451)) (125-451)), (138-213')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HOMO SAPIENS (1'-213') (V-KAPPA (HOMO SAPIENS IGKV1-39*01 (94.7%) -IGKJ5*02 (100%), CDR-IMGT (6.3.8) (27'-32'.50'-52'.89'-96')) (1'-106') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152'), V101 (190') (107'-113')); DIMER (230-230'':233-233'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G4 (232-PROLINE), ANTI-(HUMAN NATRIURETIC PEPTIDE RECEPTOR A) (HUMAN MONOCLONAL REGN5381 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN5381 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS NPR1 (NATRIURETIC PEPTIDE RECEPTOR 1, NATRIURETIC PEPTIDE RECEPTOR A, NPRA, ATRIONATRIURETIC PEPTIDE RECEPTOR A, ANPRA, GUANYLATE CYCLASE A, GUCY2A)), HOMO SAPIENS MONOCLONAL ANTIBODY, AGONIST

VIXTICIBART [INN]

VIXTICIBART [USAN]